A robust multiplex immunofluorescence and digital pathology workflow for the characterisation of the tumour immune microenvironment. Issue 10 (1st September 2020)

• Record Type: Journal Article
• Authors: Viratham Pulsawatdi, Amélie; Craig, Stephanie G.; Bingham, Victoria; McCombe, Kris; Humphries, Matthew P.; Senevirathne, Seedevi; Richman, Susan D.; Quirke, Phil; Campo, Leticia; Domingo, Enric; Maughan, Timothy S.; James, Jacqueline A.; Salto‐Tellez, Manuel
• Is Part Of: Molecular oncology. Volume 14:Issue 10(2020)
• Page Start: 2384
• Page End: 2402
• Publication Date: 2020-09-01
• Subjects: image analysis -- multiplex immunofluorescence -- opal methodology; Cancer -- Molecular aspects -- Periodicals; 616.994005
• DOI: 10.1002/1878-0261.12764
• Languages: English
• ISSNs: 1574-7891

Abstract

Abstract : Multiplex immunofluorescence is a powerful tool for the simultaneous detection of tissue‐based biomarkers, revolutionising traditional immunohistochemistry. The Opal methodology allows up to eight biomarkers to be measured concomitantly without cross‐reactivity, permitting identification of different cell populations within the tumour microenvironment. In this study, we aimed to validate a multiplex immunofluorescence workflow in two complementary multiplex panels and evaluate the tumour immune microenvironment in colorectal cancer (CRC) formalin‐fixed paraffin‐embedded tissue. We stained CRC and tonsil samples using Opal multiplex immunofluorescence on a Leica BOND RX immunostainer. We then acquired images on an Akoya Vectra Polaris and performed multispectral unmixing using inform . Antibody panels were validated on tissue microarray sections containing cores from six normal tissue types, using qupath for image analysis. Comparisons between chromogenic immunohistochemistry and multiplex immunofluorescence on consecutive sections from the same tissue microarray showed significant correlation ( r s > 0.9, P ‐value < 0.0001), validating both panels. We identified many factors that influenced the quality of the acquired fluorescent images, including biomarker co‐expression, staining order, Opal‐antibody pairing, sample thickness, multispectral unmixing and biomarker detection order during image analysis. Overall, we report the optimisation and validation of a multiplex immunofluorescence process, from staining to image analysis, ensuring assay robustness. Our multiplex immunofluorescence protocols permit the accurate detection of multiple immune markers in various tissue types, using a workflow that enables rapid processing of samples, above and beyond previous workflows. Abstract : Optimisation and validation of a multiplex immunofluorescence (mIF) workflow, from staining to digital image analysis (DIA), ensure assay robustness. Chromogenic immunohistochemistry (IHC) and fluorescent singleplexes are fundamental in this process, particularly when biomarkers are co‐expressed. We describe our experience developing two mIF panels and the various parameters of staining, scanning and DIA to consider when standardising a digital pathology workflow.